Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Rousseau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|December 1, 2001
Gene therapy for paediatric leukaemiaR F Rousseau, C M Bollard, H E Heslop
Hematology/Oncology Clinics of North America|October 26, 2001
Cancer vaccinesR F Rousseau, C Hirschmann-Jax, S Takahashi, et al.
Clinical and Experimental Medicine|December 5, 2002
Cancer vaccines: dream, reality, or nightmare?E Biagi, R F Rousseau, E Yvon, et al.
Cancer Gene Therapy|July 31, 2001
Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphomaS Takahashi, P Yotnda, R F Rousseau, et al.
Human Gene Therapy|June 28, 2001
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenesS Takahashi, R F Rousseau, P Yotnda, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|December 1, 2001
Gene therapy for paediatric leukaemiaR F Rousseau, C M Bollard, H E Heslop
Hematology/Oncology Clinics of North America|October 26, 2001
Cancer vaccinesR F Rousseau, C Hirschmann-Jax, S Takahashi, et al.
Clinical and Experimental Medicine|December 5, 2002
Cancer vaccines: dream, reality, or nightmare?E Biagi, R F Rousseau, E Yvon, et al.
Cancer Gene Therapy|July 31, 2001
Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphomaS Takahashi, P Yotnda, R F Rousseau, et al.
Human Gene Therapy|June 28, 2001
Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenesS Takahashi, R F Rousseau, P Yotnda, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Pageof 1